Abstract
A 48-year-old man presented with sudden right ear tinnitus and showed no other otoneurologic signs or symptoms. Auditory brainstem response revealed prolonged III–V interpeak latencies from stimulating either ear. MRI revealed a small, circumscribed lesion of the left inferior colliculus, probably from an acute hemorrhage leading to a small cavernous malformation. Circumscribed lesions of the inferior colliculus are rare with no prior reports of contralateral tinnitus.
References
1.
Aiba T, Tanaka R: Natural history of intracranial cavernous malformations. J Neurosurg 1995;83:56–59.
2.
Bähr M, Frotscher M: Neurologisch-topische Diagnostik. Stuttgart, Thieme, 2003, pp 176–183.
3.
Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U: Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev 2002;25:1–53.
4.
Bolzani W, Rognone F, Savoldi F, Montalbetti L: Colliculus hemorrhage. Rev Neurol (Paris) 1996;152:548–551.
5.
Chen CH, Hwang WJ, Tsai TT, Lai ML: Midbrain hemorrhage presenting with trochlear nerve palsy. Zhonghua Yi Xue Za Zhi 2000;63:138–143.
6.
Cocito D, Amedeo G, Gallo G, Vischia F, De Lucchi R: Hematoma of the inferior colliculus: uncommon cause of trochlear nerve deficit and contralateral sensory hemisyndrome. Ital J Neurol Sci 1990;11:71–74.
7.
Demanez JP, Demanez L: Anatomophysiology of the central auditory nervous system: basic concepts. Acta Otorhinolaryngol Belg 2003;57:227–236.
8.
Durrant JD, Martin WH, Hirsch B, Schwegler J: 3 CLT ABR analyses in a human subject with unilateral extirpation of the inferior colliculus. Hear Res 1994;72:99–107.
9.
Faingold CL: Role of GABA abnormalities in the inferior colliculus pathophysiology-audiogenic seizures. Hear Res 2002;168:223–237.
10.
Fritschi JA, Reulen HJ, Spetzler RF, Zabramski JM: Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir 1994;130:35–46.
11.
Ishihara K, Furutani R, Shiota J, Kawamura M: A case presenting with trochlear nerve palsy and segmental sensory disturbance due to circumscribed midbrain and upper pontine hemorrhage. Rinsho Shinkeigaku 2003;43:417–421.
12.
Johkura K, Matsumoto S, Hasegawa O, Kuroiwa Y: Defective auditory recognition after small hemorrhage in the inferior colliculi. J Neurol Sci 1998;161:91–96.
13.
Li Y, Evans MS, Faingold CL: Synaptic response patterns of neurons in the cortex of rat inferior colliculus. Hear Res 1999;137:15–28.
14.
Litovsky RY, Fligor BJ, Tramo MJ: Functional role of the human inferior colliculus in binaural hearing. Hear Res 2002;165:177–188.
15.
Liu Y, Li X, Ma C, Liu J, Lu H: Salicylate blocks L-type calcium channels in rat inferior colliculus neurons. Hear Res 2005;205:271–276.
16.
Musiek FE, Charette L, Morse D, Baran JA: Central deafness associated with midbrain lesion. J Am Acad Audiol 2004;15:133–151.
17.
Nieuwenhuys R, Voogd J, van Huijzen C: The Human Central Nervous System. Berlin, Springer, 1981, pp 117–120.
18.
Oliver DL: Ascending efferent projections of the superior olivary complex. Microsc Res Tech 2000;51:355–363.
19.
Porter RW, Detwiler PW, Spetzler RF, Lawton MT, Baskin JJ, Derksen PT, Zabramski JM: Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg 1999;90:50–58.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.